Business
ACT Drugs: WHO Advises Super Branding To Reduce Confusion
Artemisinine Combination Therapy (ACT), which is the only recommended therapy for the treatment of uncomplicated malaria, should be branded in order to reduce confusion, WHO said.
The National Professional Officer, (Malaria) for WHO Nigeria, Dr Tolu Arowolo, made the statement in an interview with newsmen in Lagos, saying branding would help patients to use the appropriate medicines.“The only recommended drug for the treatment of uncomplicated malaria in Nigeria is what we call Artemisinine Combination Therapy, meaning a combination of anti-malaria that has artemisinine derivative in it.
“I am aware from my little research that people are using oral mono therapies, like artesunate for the treatment of malaria; it is very wrong,’’ she said.
Arowolo said that in spite of all the publicity given to ACT during the World Malaria Day, many people could still not identify it.
She explained that in Nigeria there were two types of anti-malaria combination drugs that met the ACT requirements for the treatment of malaria.
She said that the ACT drugs, artemether-lumefantrine and artemisinin-amodiaquine, were not easy for many Nigerians to pronounce and so many people got confused about them.
The officer said when the people, who bought anti-malaria drugs often accepted single dosage drugs, such as artesunate, which were easily available but not effective.
“The single dose drugs do not completely cure malaria and as a result they allow more anti-malaria resilient strains to develop.” Arowolo said.
She explained that super branding would involve creating an easy to recognise symbol for an ACT and putting that symbol on the packet so that people could identify it.
Arowlo said that until the government agreed to ban single therapy malaria drugs, the confusion about ACT drugs would continue, adding that super branding would make it easier for people to find the right medicine.
”Because of the names, which are not very easy for people to pronounce,
ccommunity health physicians, public health practitioners and drug manufacturers have advised to do super branding.
“They can write on the labelling of the drug or the package of the drug that this is an ACT.
“An example is the one that is coming under the Affordable Medicine Facility for Malaria, called AMFM. It has a logo of a green leaf coming from the government.
”If it is going to be at the shops, the manufacturer can also super brand it with ACT so that people can know that this is a drug that should be used for malaria.’’
Arowolo urged Nigerians to remain vigilant in the fight against malaria, which had remained endemic in the country.
She said people should do this by starting treatment with ACT within 24 hours of the onset of malaria.
She further urged Nigerians to endeavour to complete the three-day treatment because uncompleted treatment was another factor that led to drug resistant malaria.
Business
FG Flaggs Of Renewed Hope Employment Initiative
Business
Kachikwu Makes Case For Increased NCI Fund To US$1bn … Timeline For Developing Oil Blocks
Business
FG Embarks On Sanitizing Mining Industry
-
Politics2 days ago
2027: Bayelsa APC Adopts Tinubu As Sole Candidate … As Lokpobiri, Lyon Shun Meeting
-
Sports2 days ago
GOtv Boxing Night 34 holds Dec. in Lagos
-
Politics2 days ago
Alleged Smear Campaign Against Yakubu, CSOs Demand Apology From Uzodimma
-
Sports2 days ago
WCQ: NFF Denies Post Match Statement
-
Politics2 days ago
Why INEC Can’t Punish Politicians For Early Campaigns – Yakubu
-
Politics2 days ago
2027: Jega Condemns Premature Campaigns, Blames Elected Officials
-
Politics2 days ago
Stopping Natasha’s Resumption Threatens Nigeria’s Democracy – ADC
-
Sports2 days ago
Gov. Decries Delta’s Poor Performance At 2025 NYG